Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rybelsus
Pharma
Novo, Lilly poised to overcome GLP-1 supply constraints in 2025
After a spate of manufacturing outlays, the future looks bright for supplies of Novo and Lilly's cardiometabolic GLP-1 drugs, analysts at ZS said.
Fraiser Kansteiner
Dec 30, 2024 8:00am
Novo’s chief scientific officer looks to the future of GLP-1s
Dec 13, 2024 8:50am
Novo's oral semaglutide shows heart benefits
Oct 21, 2024 10:09am
A look at the top 10 pharma drug ad spenders
Jun 7, 2024 9:08am
The top 10 pharma drug ad spenders for 2023
Jun 3, 2024 3:00am
Diabetes, weight loss TV spending climbs amid wrestle for share
Mar 27, 2024 6:56am